GPR119 Agonism Revisited: A Novel Target for Increasing β-Cell Mass?
Endocrinology
.
2020 Feb 1;161(2):bqz018.
doi: 10.1210/endocr/bqz018.
Authors
Daniela Nasteska
1
2
3
,
David J Hodson
1
2
3
Affiliations
1
Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston, United Kingdom.
2
COMPARE University of Birmingham and University of Nottingham Midlands, United Kingdom.
3
Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, United Kingdom.
PMID:
32053720
DOI:
10.1210/endocr/bqz018
No abstract available
Publication types
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Hypoglycemic Agents
Insulin-Secreting Cells*
Substances
Hypoglycemic Agents
Grants and funding
MR/S025618/1/MRC_/Medical Research Council/United Kingdom
MR/N00275X/1/MRC_/Medical Research Council/United Kingdom
MR/S025618/1/MRC_/Medical Research Council/United Kingdom